Chris it is possible but EU approval they indicate Q3 2020 and appeal decision can go as far out as Q1 2021. Clock starts on approval in Europe and time is money.
If there is a way to not optimize a business plan ( I am being kind) Amarin management will find it.
Nothing. Ruling had not been expected as first week of September ever … it was about the oral argument (first week of "every" month is a typical timing of OAs.)
r-
Meanwhile Amarin communication about EU approval was changed (Approval [by EU] vs recommendation of approval [by EMA] near end of 2020) no sign of "slow play" (yet). Q3 2020 had not been expected as approval ever.
The first sign / clue about "slow play" could come by end of June … Amarin could request extension of time (to reply to 120 Days letter).
Second: by end of July … if icosapent will not be in the agenda (List of Outstanding Issues or Opinion) it will mean they did not answer before end of May (please: note usual, 3-months deadline is end of June) … LoOI (or Opinion) could come by end of September as the earliest … and approval by late November / early December